100073-15-2

Basic information

• Product Name: Isopropenyltributylstannane
• Synonyms: Isopropenyltributylstannane;Tributyl(1-methylethenyl)stannane;2-(Tributylstannyl)propene;tributyl(prop-1-en-2-yl)stannane;Tributyl(isopropenyl)stannane;Tributylisopropenyltin;Tri-n-butylisopropenyltin;2-(Tributylstannyl)propene AldrichCPR
• CAS NO: 100073-15-2
• Molecular Formula: C₁₅H₃₂Sn
• Molecular Weight: 331.128
• Product Categories: Stannanes
• Mol File: 100073-15-2.mol
• Article Data: 10

Chemical Properties

• Melting Point: 70-70°C / 0.1
• Boiling Point: 312°C at 760 mmHg
• Flash Point: 146.4°C
• Appearance: /
• Vapor Pressure: 0.000999mmHg at 25°C
• Storage Temp.: 2-8°C
• CAS DataBase Reference: Isopropenyltributylstannane(CAS DataBase Reference)
• NIST Chemistry Reference: Isopropenyltributylstannane(100073-15-2)
• EPA Substance Registry System: Isopropenyltributylstannane(100073-15-2)

Safety Data

• Hazardous Substances Data: 100073-15-2(Hazardous Substances Data)

Usage

General Description

Isopropenyltributylstannane, also known as tributyl(isopropenyl)stannane, is a chemical compound utilized as a reagent in the field of synthetic chemistry. It is synthesized by the reaction of stannic chloride and tri-n-butylchlorotin. The compound has a clear/colorless liquid form with a molecular weight of 385.15 g/mol and it has an unpleasant smell. It is primarily used as an organometallic reagent in carbon-carbon bond-forming reactions known as Stille reactions. Despite its usefulness, it needs to be carefully handled as it can cause skin and eye irritation, skin burns, serious eye damage, or respiratory irritation.

InChI:InChI=1/3C4H9.C3H5.Sn/c3*1-3-4-2;1-3-2;/h3*1,3-4H2,2H3;1H2,2H3;/rC15H32Sn/c1-6-9-12-16(15(4)5,13-10-7-2)14-11-8-3/h4,6-14H2,1-3,5H3

Upstream product

• 27262-82-4 tributylstannylmagnesium chloride 
• 67-64-1 acetone 
• 136052-28-3 2-tributylstannylpropyl N-cyclohexylcarbamate 
• 136052-14-7 2-tributylstannylpropyl N-phenylcarbamate 
• 136052-34-1 2-tributylstannylpropyl oxalate 
• 557-93-7 2-bromoprop-1-ene 
• 1461-22-9 tributyltin chloride 
• 2065-66-9 methyl-triphenylphosphonium iodide 
• 52168-13-5 (tri-n-butylstannyl)ethanone 
• 463-49-0 1,2-propanediene 
• 13291-18-4 isopropenylmagnesium bromide 
• 136052-29-4 2-tributylstannylpropyl N-butylcarbamate 
• 937-63-3 p-Tolyl chlorothionoformate 
• 136052-44-3 2-tributylstannylpropanol 

Downstream Products

• 852948-85-7 4-fluoro-3-isopropenylbenzaldehyde 
• 1266121-78-1 2-chloro-4-isopropenyl-benzoic acid methyl ester 
• 1395029-24-9 1-methyl-4-(4-nitro-2-(prop-1-en-2-yl)phenyl)piperazine 
• 1431332-47-6 1-benzyl-4-phenyl-5-(prop-1-en-2-yl)-1H-1,2,3-triazole 
• 1472104-36-1 N-[(4-fluorophenyl)-methyl]-2-isopropenyl-6-methyl-4-morpholin-4-yl-benzamide 
• 1472104-30-5 N-[(4-chlorophenyl)-methyl]-2-isopropenyl-6-methyl-4-morpholin-4-yl-benzamide 
• 1399813-76-3 2-(2-isopropenylbenzyl)thiophene 
• 1399813-74-1 2-{[2-(4-methylbenzyl)]phenyl}propene 

Relevant articles and documents

Novel Phosphinic Acid-Containing Thyromimetics

The present invention relates to compounds of phosphonic acid-containing T3 mimetics and monoesters thereof, stereoisomers, pharmaceutically acceptable salts, co-crystals, and prodrugs thereof and pharmaceutically acceptable salts and co-crystals of the prodrugs, as well as their preparation and uses for preventing and/or treating metabolic diseases such as obesity, NASH, hypercholesterolemia and hyperlipidemia, as well as associated conditions such as atherosclerosis, coronary heart disease, impaired glucose tolerance, metabolic syndrome x and diabetes.

Amino-substituted heterocycles, compositions thereof, and methods of treatment therewith

Provided herein are Heterocyclic Compounds having the following structure: wherein R1, R2, X, Y and Z are as defined herein, compositions comprising an effective amount of a Heterocyclic Compound and methods for treating or preventing cancer, inflammatory conditions, immunological conditions, metabolic conditions and conditions treatable or preventable by inhibition of a kinase pathway comprising administering an effective amount of a Heterocyclic Compound to a patient in need thereof.

A New Synthesis of Vinyltins by Reaction of Phosphorus Ylides with Acyltins

Acyltins react with various phosphorus ylides to afford the corresponding vinyltin derivatives, an alternative methodology for the preparation of these useful reagents.This method has been applied to the synthesis of functionally substituted vinyltins.